Cellular Targets of Nitric Oxide in the Hippocampus

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Bartus, Katalin ^a,b   Pigott, Beatrice ^a   Garthwaite, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 GUANYLATE CYCLASE SUBUNIT; BETA1 GUANYLATE CYCLASE SUBUNIT; CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE; SPLEEN EXONUCLEASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTERNEURON; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NERVE FIBER; NONHUMAN; PYRAMIDAL NERVE CELL; RAT; SUBICULUM;

ANIMALS; GUANYLATE CYCLASE; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE;

EID: 84874379499     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057292     Document Type: Article

References (54)

1. Garthwaite J, (2008) Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27: 2783-2802.
2. Loscalzo J, Welch G, (1995) Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 38: 87-104.
3. MacMicking J, Xie QW, Nathan C, (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350.
4. Alderton WK, Cooper CE, Knowles RG, (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615.
5. Friebe A, Koesling D, (2009) The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. Nitric Oxide 21: 149-156.
6. Bender AT, Beavo JA, (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58: 488-520.
7. Feil R, Kleppisch T, (2008) NO/cGMP-dependent modulation of synaptic transmission. Handb Exp Pharmacol 184: 529-560.
8. Bliss TVP, Collingridge GL, (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39.
9. Hopper RA, Garthwaite J, (2006) Tonic and phasic nitric oxide signals in hippocampal long-term potentiation. J Neurosci 26: 11513-11521.
10. Taqatqeh F, Mergia E, Neitz A, Eysel UT, Koesling D, et al. (2009) More than a retrograde messenger: nitric oxide needs two cGMP pathways to induce hippocampal long-term potentiation. J Neurosci 29: 9944-9350.
11. Arancio O, Kandel ER, Hawkins RD, (1995) Activity-dependent long-term enhancement of transmitter release by presynaptic 3′,5′-cyclic GMP in cultured hippocampal neurons. Nature 376: 74-80.
12. Arancio O, Kiebler M, Lee CJ, Lev-Ram V, Tsien RY, et al. (1996) Nitric oxide acts directly in the presynaptic neuron to produce long-term potentiation in cultured hippocampal neurons. Cell 87: 1025-1035.
13. Arancio O, Antonova I, Gambaryan S, Lohmann SM, Wood JS, et al. (2001) Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation. J Neurosci 21: 143-149.
14. Lu YF, Kandel ER, Hawkins RD, (1999) Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J Neurosci 19: 10250-10261.
15. Serulle Y, Zhang S, Ninan I, Puzzo D, McCarthy M, et al. (2007) A GluR1-cGKII interaction regulates AMPA receptor trafficking. Neuron 56: 670-688.
16. Wang HG, Lu FM, Jin I, Udo H, Kandel ER, et al. (2005) Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins. Neuron 45: 389-403.
17. Cserep C, Szonyi A, Veres JM, Nemeth B, Szabadits E, et al. (2011) Nitric oxide signaling modulates synaptic transmission during early postnatal development. Cereb Cortex 21: 2065-2074.
18. Makara JK, Katona I, Nyiri G, Nemeth B, Ledent C, et al. (2007) Involvement of nitric oxide in depolarization-induced suppression of inhibition in hippocampal pyramidal cells during activation of cholinergic receptors. J Neurosci 27: 10211-10222.
19. Boess FG, Hendrix M, van der Staay FJ, Erb C, Schreiber R, et al. (2004) Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance. Neuropharmacology 47: 1081-1092.
20. Boulton CL, Irving AJ, Southam E, Potier B, Garthwaite J, et al. (1994) The nitric oxide-cyclic GMP pathway and synaptic depression in rat hippocampal slices. Eur J Neurosci 6: 1528-1535.
21. de Vente J, Hopkins DA, Markerink-van Ittersum M, Emson PC, Schmidt HH, et al. (1998) Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain. Neuroscience 87: 207-241.
22. de Vente J, Hopkins DA, Markerink-van Ittersum M, Steinbusch HW, (1996) Effects of the 3′,5′-phosphodiesterase inhibitors isobutylmethylxanthine and zaprinast on NO-mediated cGMP accumulation in the hippocampus slice preparation: an immunocytochemical study. J Chem Neuroanat 10: 241-248.
23. Szabadits E, Cserep C, Szonyi A, Fukazawa Y, Shigemoto R, et al. (2011) NMDA receptors in hippocampal GABAergic synapses and their role in nitric oxide signaling. J Neurosci 31: 5893-5904.
24. van Staveren WC, Markerink-van Ittersum M, Steinbusch HW, Behrends S, de Vente J, (2005) Localization and characterization of cGMP-immunoreactive structures in rat brain slices after NO-dependent and NO-independent stimulation of soluble guanylyl cyclase. Brain Res 1036: 77-89.
25. van Staveren WC, Steinbusch HW, Markerink-van Ittersum M, Behrends S, de Vente J, (2004) Species differences in the localization of cGMP-producing and NO-responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry. Eur J Neurosci 19: 2155-2168.
26. van Staveren WC, Markerink-van Ittersum M, Steinbusch HW, de Vente J, (2001) The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat. Brain Res 888: 275-286.
27. van Staveren WC, Steinbusch HW, Markerink-van Ittersum M, Repaske DR, Goy MF, et al. (2003) mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain. J Comp Neurol 467: 566-580.
28. Wilson GW, Garthwaite J, (2010) Hyperpolarization-activated ion channels as targets for nitric oxide signalling in deep cerebellar nuclei. Eur J Neurosci 31: 1935-1945.
29. Garthwaite G, Garthwaite J, (1989) Neurotoxicity of excitatory amino acid receptor agonists in young rat hippocampal slices. J Neurosci Methods 29: 33-42.
30. East SJ, Garthwaite J, (1991) NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway. Neurosci Lett 123: 17-19.
31. Stasch JP, Becker EM, Alonso-Alija C, Apeler H, Dembowsky K, et al. (2001) NO-independent regulatory site on soluble guanylate cyclase. Nature 410: 212-215.
32. Roy B, Halvey EJ, Garthwaite J, (2008) An enzyme-linked receptor mechanism for nitric oxide-activated guanylyl cyclase. J Biol Chem 283: 18841-18851.
33. Wood KC, Batchelor AM, Bartus K, Harris KL, Garthwaite G, et al. (2011) Picomolar nitric oxide signals from central neurons recorded using ultrasensitive detector cells. J Biol Chem 286: 43172-43181.
34. Fukutani T, Iino S, Nojyo Y, (2009) The expression of soluble guanylate cyclase in the vasculature of rat skeletal muscle. Arch Histol Cytol 72: 117-126.
35. Szabadits E, Cserep C, Ludanyi A, Katona I, Gracia-Llanes J, et al. (2007) Hippocampal GABAergic synapses possess the molecular machinery for retrograde nitric oxide signaling. J Neurosci 27: 8101-8111.
36. Iino S, Horiguchi K, Nojyo Y, (2008) Interstitial cells of Cajal are innervated by nitrergic nerves and express nitric oxide-sensitive guanylate cyclase in the guinea-pig gastrointestinal tract. Neuroscience 152: 437-448.
37. Lin DT, Fretier P, Jiang C, Vincent SR, (2010) Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons. Synapse 64: 460-466.
38. Huang R, Shi F, Lei T, Song Y, Hughes CL, et al. (2007) Effect of the isoflavone genistein against galactose-induced cataracts in rats. Exp Biol Med (Maywood) 232: 118-125.
39. Watanabe M, Fukaya M, Sakimura K, Manabe T, Mishina M, et al. (1998) Selective scarcity of NMDA receptor channel subunits in the stratum lucidum (mossy fibre-recipient layer) of the mouse hippocampal CA3 subfield. Eur J Neurosci 10: 478-487.
40. Friebe A, Mergia E, Dangel O, Lange A, Koesling D, (2007) Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase. Proc Natl Acad Sci U S A 104: 7699-7704.
41. de Vente J, Steinbusch HW, Schipper J, (1987) A new approach to immunocytochemistry of 3′,5′-cyclic guanosine monophosphate: preparation, specificity, and initial application of a new antiserum against formaldehyde-fixed 3′,5′-cyclic guanosine monophosphate. Neuroscience 22: 361-373.
42. Tanaka J, Markerink-van Ittersum M, Steinbusch HW, de Vente J, (1997) Nitric oxide-mediated cGMP synthesis in oligodendrocytes in the developing rat brain. Glia 19: 286-297.
43. Bellamy TC, Garthwaite J, (2001) "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide. Mol Pharmacol 59: 54-61.
44. Ventura R, Harris KM, (1999) Three-dimensional relationships between hippocampal synapses and astrocytes. J Neurosci 19: 6897-6906.
45. Hall CN, Garthwaite J, (2006) Inactivation of nitric oxide by rat cerebellar slices. J Physiol 577: 549-567.
46. Mo E, Amin H, Bianco IH, Garthwaite J, (2004) Kinetics of a cellular nitric oxide/cGMP/phosphodiesterase-5 pathway. J Biol Chem 279: 26149-26158.
47. Mullershausen F, Russwurm M, Thompson WJ, Liu L, Koesling D, et al. (2001) Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme. J Cell Biol 155: 271-278.
48. van Langen J, Fransen P, van Hove CE, chrijvers DM, artinet W, et al. (2012) Selective loss of basal but not receptor-stimulated relaxation by endothelial nitric oxide synthase after isolation of the mouse aorta. Eur J Pharmacol 696: 111-119.
49. Gibb BJ, Garthwaite J, (2001) Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain. Eur J Neurosci 13: 539-544.
50. Matsuoka I, Giuili G, Poyard M, Stengel D, Parma J, et al. (1992) Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J Neurosci 12: 3350-3360.
51. Pifarre P, Garcia A, Mengod G, (2007) Species differences in the localization of soluble guanylyl cyclase subunits in monkey and rat brain. J Comp Neurol 500: 942-957.
52. Burette A, Zabel U, Weinberg RJ, Schmidt HH, Valtschanoff JG, (2002) Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus. J Neurosci 22: 8961-8970.
53. Ding JD, Burette A, Nedvetsky PI, Schmidt HH, Weinberg RJ, (2004) Distribution of soluble guanylyl cyclase in the rat brain. J Comp Neurol 472: 437-448.
54. Neitz A, Mergia E, Eysel UT, Koesling D, Mittmann T, (2011) Presynaptic nitric oxide/cGMP facilitates glutamate release via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus. Eur J Neurosci 33: 1611-1621.